Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Official URL: https://fevir.net/resources/EvidenceVariable/367896 | Version: 1.0.0-ballot3 | ||||
| Standards status: Informative | Computable Name: Percentage_of_Participants_With_Serious_Adverse_Events_SAEs_NCT03640312 | ||||
| Other Identifiers: FEvIR Object Identifier: FEvIR Object Identifier#367896, FEvIR Linking Identifier: NCT03640312-otherOutcome-0, OID:2.16.840.1.113883.4.642.40.44.24.171 | |||||
Copyright/Legal: Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse). |
|||||
Percentage of participants with any Serious Adverse Events (SAE) according to Good Clinical Practice definition: adverse events that result in death, are life threatening, require hospitalization or prolong existing hospitalization, result in persistent disability, result in congenital anomaly or birth defect, or unimportant medical event that requires intervention to prevent any of the above.
version: 31; Last updated: 2026-09-08 12:21:25+0000
Profile: VariableDefinition
ArtifactPublicationStatus: Active
url: EvidenceVariable Percentage of Participants With Serious Adverse Events (SAEs) (NCT03640312)
identifier: FEvIR Object Identifier/367896, FEvIR Linking Identifier/NCT03640312-otherOutcome-0, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.24.171
version: 1.0.0-ballot3
name: Percentage_of_Participants_With_Serious_Adverse_Events_SAEs_NCT03640312
title: Percentage of Participants With Serious Adverse Events (SAEs) (NCT03640312)
citeAs:
Percentage of Participants With Serious Adverse Events (SAEs) (NCT03640312) [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 367896. Revised 2026-09-08. Available at: https://fevir.net/resources/EvidenceVariable/367896. Computable resource at: https://fevir.net/resources/EvidenceVariable/367896#json.
status: Active
date: 2026-11-05 14:34:28+0000
author: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter:
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
description:
Percentage of participants with any Serious Adverse Events (SAE) according to Good Clinical Practice definition: adverse events that result in death, are life threatening, require hospitalization or prolong existing hospitalization, result in persistent disability, result in congenital anomaly or birth defect, or unimportant medical event that requires intervention to prevent any of the above.
copyright:
Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).
| Concept |
| Percentage of Participants With Serious Adverse Events (SAEs) Percentage of participants with any Serious Adverse Events (SAE) according to Good Clinical Practice definition: adverse events that result in death, are life threatening, require hospitalization or prolong existing hospitalization, result in persistent disability, result in congenital anomaly or birth defect, or unimportant medical event that requires intervention to prevent any of the above. |
handling: Evidence variable handling not specified
| Text |
| 12 weeks |